Sagimet Biosciences (SGMT) Gains from Investment Securities (2023 - 2024)
Historic Gains from Investment Securities for Sagimet Biosciences (SGMT) over the last 2 years, with Q3 2024 value amounting to $4.3 million.
- Sagimet Biosciences' Gains from Investment Securities rose 1475.8% to $4.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.3 million, marking a year-over-year increase of 1475.8%. This contributed to the annual value of $149000.0 for FY2024, which is 9603.04% down from last year.
- Latest data reveals that Sagimet Biosciences reported Gains from Investment Securities of $4.3 million as of Q3 2024, which was up 1475.8% from $4.5 million recorded in Q2 2024.
- In the past 5 years, Sagimet Biosciences' Gains from Investment Securities registered a high of $4.5 million during Q2 2024, and its lowest value of -$1000.0 during Q2 2023.